Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RetinaLyze
Denmark
- Ownership
- Private
- Development stage
- Other
01
Overview
Commercial AI software for automated analysis of fundus images and OCT scans to detect eye diseases like diabetic retinopathy, AMD, glaucoma, and potentially Alzheimer's.
- Therapeutic areas
- NeurologyOphthalmology
- Industry
- Digital Health Medical Devices
02
Partnerships
National Eyepa Coalition
Beyond the preview
Go deeper on RetinaLyze.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RetinaLyze.